BUSCOPAN INJECTION 50ML

Description

Buscopan injectable 50ML solution is indicated for the control of abdominal pain (colic) associated with spasmodic colic, flatulent colic, and simple impactions in horses. Buscopan is an antispasmodic (spasmolytic) and anticholinergic drug which suppresses spasms of the digestive system

 

Benefits:

• Suppresses spasms of the digestive system.
• The effectiveness of Buscopan was also supported by the overall improvement in the behavioral attitudes of the horses.

Indications:

Buscopan is indicated for the control of abdominal pain colic associated with spasmodic colic, flatulent colic, and simple impactions in horses.

Contraindications:BUSCOPAN INJECTION 50ML

Buscopan should not be used in impaction colics associated with ileus, or in horses with glaucoma.

Warnings:BUSCOPAN INJECTION 50ML

Do not use in horses intended for human consumption. Not for use in humans. Keep out of reach of children. If ingested, contact a physician immediately.

Precautions:BUSCOPAN INJECTION 50ML

Buscopan is not recommended for use in nursing foals or in pregnant or lactating mares, as safety has not been established. The effects of Buscopan may be potentiated by the concomitant use of other anticholinergic drugs. Studies of concomitant administration of Buscopan with other drugs have not been conducted. Drug compatibility should be monitored closely in patients requiring adjunctive therapy. The safety of Buscopan has not been established for intramuscular IM administration. Administration of Buscopan results in heart rate elevation. Heart rate can not be used as a valid indicator of severity of pain for 30 minutes following IV injection.

Adverse Reactions:BUSCOPAN INJECTION 50ML

Transient tachycardia and decreased borborygmal sounds lasted approximately 30 minutes following administration. Transient pupillary dilation may also be observed.

Manufactured for: Boehringer Ingelheim Vetmedica, Inc., St. Joseph, MO 64506 Buscopan is a registered trademark of Boehringer Ingelheim Pharma GmbH & Co. KG and used under license.

 

BUSCOPAN INJECTION 50ML is not recommended for use in nursing foals or in pregnant or lactating mares, as safety has not been established. The effects of Buscopan may be potentiated by the concomitant use of other anticholinergic drugs. Studies of concomitant administration of Buscopan with other drugs have not been conducted. Drug compatibility should be monitored closely in patients requiring adjunctive therapy. The safety of Buscopan has not been established for intramuscular IM administration. Administration of Buscopan results in heart rate elevation. Heart rate can not be used as a valid indicator of severity of pain for 30 minutes following IV injection.

Adverse Reactions:BUSCOPAN INJECTION 50ML

Transient tachycardia and decreased borborygmal sounds lasted approximately 30 minutes following administration. Transient pupillary dilation may also be observed.

Manufactured for: Boehringer Ingelheim Vetmedica, Inc., St. Joseph, MO 64506 Buscopan is a registered trademark of Boehringer Ingelheim Pharma GmbH & Co. KG and used under licensehttps://enongvetmedication.com/